Watanabe K et al. |
Donor bone marrow cell facilitates induction of tolerance to kidney allografts in dogs treated with fractionated lymphoid irradiation and FK 506. |
1991 |
Transplant. Proc. |
pmid:1703706
|
Undre NA et al. |
Pharmacokinetics of FK 506 and mycophenolic acid after the administration of a FK 506-based regimen in combination with mycophenolate mofetil in kidney transplantation. |
1998 |
Transplant. Proc. |
pmid:9636527
|
Gutiérrez Sánchez MJ et al. |
Optimization of immunosuppression by switching from azathioprine to enteric-coated mycophenolate sodium in stable kidney transplant patients. |
2009 Jul-Aug |
Transplant. Proc. |
pmid:19715907
|
Diez Ojea B et al. |
Three-month experience with tacrolimus once-daily regimen in stable renal allografts. |
2009 Jul-Aug |
Transplant. Proc. |
pmid:19715908
|
Gruessner RW et al. |
Mycophenolate mofetil and tacrolimus for induction and maintenance therapy after pancreas transplantation. |
1998 |
Transplant. Proc. |
pmid:9532156
|
Aptaramanov B et al. |
A comparison of mycophenolate mofetil with mycophenolate sodium in renal transplant recipients on tacrolimus-based treatment. |
2011 |
Transplant. Proc. |
pmid:21486609
|
Ma A et al. |
Immunological evaluation of combination therapy with tacrolimus and sirolimus on long-term allograft survival in nonhuman primates. |
2005 Jan-Feb |
Transplant. Proc. |
pmid:15808578
|
Dheir H et al. |
Intensive polyoma virus nephropathy treatment as a preferable approach for graft surveillance. |
2011 |
Transplant. Proc. |
pmid:21486617
|
Waller JR et al. |
Mycophenolate mofetil inhibits intimal hyperplasia and attenuates the expression of genes favouring smooth muscle cell proliferation and migration. |
2005 Jan-Feb |
Transplant. Proc. |
pmid:15808582
|
Hayashi S et al. |
Adenovirus-mediated gene transfer to the xenogeneic liver in liver xenotransplantation: the transduction of complement regulatory factor genes (DAF and HRF20). |
1997 |
Transplant. Proc. |
pmid:9193595
|
Jang HJ et al. |
Tacrolimus for rescue therapy in refractory renal allograft rejection. |
2000 |
Transplant. Proc. |
pmid:11119925
|
Morita H et al. |
Acceptance of skin xenografts (from guinea pig to mice) by portal venous and intravenous injections of donor hematolymphoid cells. |
2000 |
Transplant. Proc. |
pmid:10715422
|
Zeevi A et al. |
Comparative in vitro studies on the immunosuppressive effects of purine and pyrimidine synthesis inhibitors. |
1993 |
Transplant. Proc. |
pmid:7679843
|
Shimada H et al. |
Existence of serum p53 antibodies in cyclosporine A-treated transplant patients: possible detection of p53 protein over-expression. |
2000 |
Transplant. Proc. |
pmid:11119931
|
Vela CG et al. |
Prospective study of lipid disorders in FK506-versus cyclosporine-treated renal transplant patients. |
2000 |
Transplant. Proc. |
pmid:10715453
|
Ali Shah I et al. |
Effects of FK 506 on human hepatic microsomal cytochrome P-450-dependent drug metabolism in vitro. |
1991 |
Transplant. Proc. |
pmid:1721276
|
Moochhala SM et al. |
Inhibition of drug metabolism in rat and human liver microsomes by FK 506 and cyclosporine. |
1991 |
Transplant. Proc. |
pmid:1721277
|
Wakizaka Y et al. |
Xenotransplantation of hamster liver into Gunn rats reserves congenital hyperbilirubinemia. |
1996 |
Transplant. Proc. |
pmid:8623372
|
Pan F et al. |
Effect of tacrolimus and splenectomy on engraftment and GVHD after bone marrow xenotransplantation in the reciprocal hamster to rat animal models. |
1996 |
Transplant. Proc. |
pmid:8623373
|
Francavilla A et al. |
FK 506 as a growth control factor. |
1990 |
Transplant. Proc. |
pmid:1689912
|
Mazzaferro V et al. |
Studies of the hepatotrophic qualities of FK 506 and CyA. |
1990 |
Transplant. Proc. |
pmid:1689913
|
Land W et al. |
Mycophenolate mofetil monotherapy: an optimal, safe, and efficacious immunosuppressive maintenance regimen in kidney transplant patients. |
2001 |
Transplant. Proc. |
pmid:11406265
|
Serrano M et al. |
Clinical value of a single determination of intracellular ATP levels in stimulated CD4+ T lymphocytes in pediatric patients with stable liver transplantation. |
2012 |
Transplant. Proc. |
pmid:23146475
|
Charco R et al. |
Hypercholesterolemia in long-term survivors of liver transplantation: a comparison between cyclosporine and FK 506. |
1998 |
Transplant. Proc. |
pmid:9636605
|
Liu M et al. |
C4d-positive acute humoral renal allograft rejection: rescue therapy by immunoadsorption in combination with tacrolimus and mycophenolate mofetil. |
2004 |
Transplant. Proc. |
pmid:15518760
|
Resch B et al. |
FK 506 and successful pregnancy in a patient after renal transplantation. |
1998 |
Transplant. Proc. |
pmid:9474990
|
Rucay P et al. |
FK 506 as treatment of late acute rejection in liver transplant patients. |
1995 |
Transplant. Proc. |
pmid:7533354
|
Hampel G et al. |
Different effects of cyclosporine and tacrolimus on the activation of mesangial metalloproteinases and their inhibitors. |
1999 |
Transplant. Proc. |
pmid:10578279
|
Katz HR et al. |
Mast cell biochemical and functional heterogeneity. |
1991 |
Transplant. Proc. |
pmid:1721308
|
Ishibashi M et al. |
Elimination of the adverse effects of tacrolimus-based induction therapy by a 5-day exposure of optimal steady-state blood concentration in renal transplant patients in the early postoperative period. |
1999 |
Transplant. Proc. |
pmid:10578281
|
Propper DJ et al. |
Low-dose FK 506 inhibits sensitisation after blood transfusions. |
1990 |
Transplant. Proc. |
pmid:1697114
|
Marente VC et al. |
Modigraf administration through jejunostomy in liver transplant recipient: case report. |
2013 |
Transplant. Proc. |
pmid:24314992
|
González-Pinto IM et al. |
Five-year follow-up of a trial comparing Tacrolimus and cyclosporine microemulsion in liver transplantation. |
2005 |
Transplant. Proc. |
pmid:15919441
|
Maes BD and Vanrenterghem YF |
Cyclosporine: advantages versus disadvantages vis-Ã -vis tacrolimus. |
2004 |
Transplant. Proc. |
pmid:15041305
|
Hesselink DA et al. |
The use of cyclosporine in renal transplantation. |
2004 |
Transplant. Proc. |
pmid:15041316
|
Ã…berg F et al. |
Asymptomatic De Novo Inflammatory Bowel Disease Late After Liver Transplantation for Primary Sclerosing Cholangitis: A Case Report. |
2015 |
Transplant. Proc. |
pmid:26680092
|
Malireddy SR et al. |
Altered first-pass effects in a liver transplant recipient explained intraindividual variation in calcineurin inhibitor concentrations: a case report. |
2008 |
Transplant. Proc. |
pmid:18589198
|
Fukuzaki T et al. |
Induction of unresponsiveness to islet allografts with donor spleen cell inoculation followed by a single injection of FK 506. |
1995 |
Transplant. Proc. |
pmid:7533407
|
Grochowicz PM et al. |
Synergism of castanospermine and FK 506. |
1995 |
Transplant. Proc. |
pmid:7533408
|
Reding R et al. |
Compassionate use of FK 506 in pediatric liver transplantation: a pilot study. |
1991 |
Transplant. Proc. |
pmid:1721341
|
Lee KK et al. |
Comparison of short-term immunosuppressive therapy with cyclosporine and FK 506 in small-bowel transplantation. |
1990 |
Transplant. Proc. |
pmid:1702239
|
Allers C et al. |
Tacrolimus, daclizumab, sirolimus, and budesonide after small bowel transplantation in order to reduce nephrotoxicity. |
2002 |
Transplant. Proc. |
pmid:12034251
|
Hodge EE et al. |
Use of mycophenolate mofetil in liver transplant recipients experiencing renal dysfunction on cyclosporine or tacrolimus-randomized, prospective, multicenter study results. |
2002 |
Transplant. Proc. |
pmid:12176477
|
Chiereghin A et al. |
Monitoring cytomegalovirus T-cell immunity in small bowel/multivisceral transplant recipients. |
2010 Jan-Feb |
Transplant. Proc. |
pmid:20172283
|
Dierickx D et al. |
Thrombotic microangiopathy following intestinal transplantation: a single center experience. |
2010 Jan-Feb |
Transplant. Proc. |
pmid:20172285
|
Ahlmén J et al. |
Positive effects of tacrolimus in a case of CIDP. |
1998 |
Transplant. Proc. |
pmid:9865344
|
Chmiel B et al. |
Rheological properties of red blood cells in kidney transplant recipients: the role of lipid profile and type of immunosuppresion. |
2005 |
Transplant. Proc. |
pmid:15919493
|
Prasad GV et al. |
Role of dietary salt intake in posttransplant hypertension with tacrolimus-based immunosuppression. |
2005 |
Transplant. Proc. |
pmid:15919496
|
Gaber LW et al. |
Renal histology with varying FK506 blood levels. |
1997 Feb-Mar |
Transplant. Proc. |
pmid:9122955
|
Cohen DS et al. |
Porcine small bowel transplantation with rapamycin-based induction immunosuppression and short-course cyclosporine or FK 506 therapy. |
1996 |
Transplant. Proc. |
pmid:8907923
|
Malaise J et al. |
Immunosuppressive drugs after simultaneous pancreas-kidney transplantation. |
2005 Jul-Aug |
Transplant. Proc. |
pmid:16182827
|
Malaise J et al. |
Tacrolimus compared with cyclosporine microemulsion in primary simultaneous pancreas-kidney transplantation: the EURO-SPK 3-year results. |
2005 Jul-Aug |
Transplant. Proc. |
pmid:16182828
|
Kitamura M et al. |
Clinical experience of FK 506 for renal allograft transplantation. |
1994 |
Transplant. Proc. |
pmid:7520611
|
Zmonarski SC et al. |
Lowering of Messenger Ribonucleic Acid Toll-Like Receptors 2-4,9 in Peripheral Blood Mononuclear Cells in Kidney Allograft Recipients, Relationships With Immunosuppressive Treatment, and Delayed Graft Function Occurrence. |
2016 |
Transplant. Proc. |
pmid:27496439
|
Fung JJ et al. |
Adverse effects associated with the use of FK 506. |
1991 |
Transplant. Proc. |
pmid:1721372
|
Omar G et al. |
FK 506 inhibition of cyclosporine metabolism by human liver microsomes. |
1991 |
Transplant. Proc. |
pmid:1703356
|
Lama R et al. |
Lung transplants with tacrolimus and mycophenolate mofetil: a review. |
2003 |
Transplant. Proc. |
pmid:12962866
|
Crespo-Leiro MG |
Tacrolimus in heart transplantation. |
2003 |
Transplant. Proc. |
pmid:12962869
|
Campos HH and Abbud Filho M |
One-year follow-up of a Brazilian randomized multicenter study comparing tacrolimus versus cyclosporine in kidney transplantation. |
2002 |
Transplant. Proc. |
pmid:12176523
|
Zegarska J et al. |
Evaluation of the Relationship Between Concentrations of Tacrolimus Metabolites, 13-O-Demethyl Tacrolimus and 15-O-Demethyl Tacrolimus, and Clinical and Biochemical Parameters in Kidney Transplant Recipients. |
2018 |
Transplant. Proc. |
pmid:30177142
|
Dietl KH |
Oral dosing of tacrolimus and cyclosporine microemulsion--results from a large multicenter study in renal transplantation. |
2002 |
Transplant. Proc. |
pmid:12176524
|
Shapiro R et al. |
Reversibility of tacrolimus-induced posttransplant diabetes: an illustrative case and review of the literature. |
1997 |
Transplant. Proc. |
pmid:9290809
|
Han DJ et al. |
A 39-month follow-up study to evaluate the safety and efficacy in kidney transplant recipients treated with modified-release tacrolimus (FK506E)-based immunosuppression regimen. |
2012 |
Transplant. Proc. |
pmid:22310592
|
Kumano K et al. |
Role of the transforming growth factor and monocyte chemoattractant protein in FK506-induced nephropathy in the rat. |
1997 Feb-Mar |
Transplant. Proc. |
pmid:9123293
|
Wilczek HE et al. |
Renal transplant histopathologic changes during the first year in patients with tacrolimus (FK 506). |
1996 |
Transplant. Proc. |
pmid:8962232
|
Chang HR et al. |
Lack of hepatotoxicity upon sirolimus addition to a calcineurin inhibitor-based regimen in hepatitis virus-positive renal transplant recipients. |
2007 |
Transplant. Proc. |
pmid:17580178
|
Bhaloo S and Prasad GV |
Severe reduction in tacrolimus levels with rifampin despite multiple cytochrome P450 inhibitors: a case report. |
2003 |
Transplant. Proc. |
pmid:14611983
|
Jacobs TW et al. |
The effect of FK 506, cyclosporine A, and cyclosporine G on serum 1,25-dihydroxyvitamin D levels. |
1991 |
Transplant. Proc. |
pmid:1721403
|
Yoshimura R et al. |
A comparative study of cyclosporine vs FK 506: role of kidney microsomal cytochrome P-450. |
1992 |
Transplant. Proc. |
pmid:1379755
|
Baruch Y et al. |
Anasarca and hypertrophic cardiomyopathy in a liver transplant patient on FK506: relieved after a switch to Neoral. |
1996 |
Transplant. Proc. |
pmid:8769215
|
Melter M et al. |
Successful reconversion from tacrolimus to cyclosporine A Neoral in pediatric liver recipients. |
1996 |
Transplant. Proc. |
pmid:8769224
|
Arai K et al. |
Prolonged limb allograft survival with short-term treatment with FK-506 in rats. |
1989 |
Transplant. Proc. |
pmid:2468256
|
Migita K and Eguchi K |
FK 506-mediated T-cell apoptosis induction. |
2001 |
Transplant. Proc. |
pmid:11377532
|
Omoto K et al. |
Adverse events in renal transplantation under tacrolimus/mycophnolate mofetil immunosuppression: a single-center experience. |
2002 |
Transplant. Proc. |
pmid:12176591
|
Reutzel-Selke A et al. |
Donor pretreatment of grafts from marginal donors improves long-term graft outcome. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267150
|
Fábrega E et al. |
Effect of immunosuppressant blood levels on serum concentration of interleukin-17 and -23 in stable liver transplant recipients. |
2009 |
Transplant. Proc. |
pmid:19376417
|
Rayes N et al. |
Distribution of lymphocyte subtypes in liver transplant recipients with viral reinfection or de novo malignancy. |
1998 |
Transplant. Proc. |
pmid:9723303
|
Sánchez Pérez B et al. |
Adverse effects on the lipid profile of immunosuppressive regimens: tacrolimus versus cyclosporin measured using C2 levels. |
2009 |
Transplant. Proc. |
pmid:19376418
|
Reggiani P et al. |
Reduced acute rejection after liver transplantation with Neoral-based double immunosuppression. |
1998 |
Transplant. Proc. |
pmid:9723308
|
Tahir W et al. |
Diffuse Alveolar haemorrhage: a fatal complication after alemtuzumab induction therapy in renal transplantation. |
|
Transplant. Proc. |
pmid:25645795
|
Kishikawa H et al. |
Low-dose steroid maintenance for renal transplant recipients. |
2010 |
Transplant. Proc. |
pmid:21168618
|
Kovarik JM et al. |
Differential pharmacokinetic interaction of tacrolimus and cyclosporine on everolimus. |
2006 |
Transplant. Proc. |
pmid:17175302
|
Moura Neto A et al. |
Clinical Profile of Patients With Diabetes Mellitus and Liver Transplantation: Results After a Multidisciplinary Team Intervention. |
2018 |
Transplant. Proc. |
pmid:29661438
|
Wada H et al. |
An attempt to induce tolerance to skin grafts in congenic mice with FK 506. |
1991 |
Transplant. Proc. |
pmid:1721435
|
Kuroki H et al. |
Synergistic effect of FK 506 and donor-specific blood transfusion on rat skin but not on composite tissue (limb) allograft survival. |
1991 |
Transplant. Proc. |
pmid:1721436
|
Calne R et al. |
Observations about FK-506 in primates. |
1987 |
Transplant. Proc. |
pmid:2445078
|
Todo S et al. |
Orthotopic liver transplantation in dogs receiving FK-506. |
1987 |
Transplant. Proc. |
pmid:2445079
|
Jain A et al. |
Prospective randomized trial of tacrolimus and prednisone versus tacrolimus, prednisone, and mycophenolate mofetil: complete report on 350 primary adult liver transplantations. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267319
|
Torregrosa JV et al. |
Combined liver-kidney transplantation: our experience. |
1999 |
Transplant. Proc. |
pmid:10500591
|
Fischer S et al. |
Initial experience of combined immunosuppressive induction therapy with polyclonal antithymocyte antibody, FK 506 (tacrolimus), and prednisolone in clinical liver transplantation. |
2000 |
Transplant. Proc. |
pmid:11134815
|
Chamienia A et al. |
Open prospective study to evaluate cardiovascular risk factors and renal function in 2 dosage regimens of tacrolimus combined with mycophenolate mofetil and steroids in renal transplant patients: 5-year results. |
2014 |
Transplant. Proc. |
pmid:25380901
|
Kocak H et al. |
Tacrolimus plus low-dose mycophenolate mofetil in renal transplant recipients: better 2-year graft and patient survival than with a higher mycophenolate mofetil dose. |
2005 |
Transplant. Proc. |
pmid:16213288
|
Abou-Jaoude MM et al. |
Tacrolimus (FK506) versus cyclosporine microemulsion (neoral) as maintenance immunosuppression therapy in kidney transplant recipients. |
2005 |
Transplant. Proc. |
pmid:16213293
|
Abe T et al. |
Risk factors for development of new-onset diabetes mellitus and progressive impairment of glucose metabolism after living-donor liver transplantation. |
2014 |
Transplant. Proc. |
pmid:24767367
|
Takahashi K et al. |
Tacrolimus therapy for ABO-incompatible kidney transplantation. |
1998 |
Transplant. Proc. |
pmid:9636495
|
Braun F et al. |
Primary low-dose tacrolimus immunosuppressive prophylaxis for high-risk kidney transplant recipients. |
1998 |
Transplant. Proc. |
pmid:9636496
|
Bresci S et al. |
Case report: cystic fibrosis, lung transplantation, and the novel H1N1 flu. |
2010 Jul-Aug |
Transplant. Proc. |
pmid:20692461
|
White SA et al. |
Influence of delayed graft function in renal transplants from cadaveric or non-heart-beating donors. |
2000 |
Transplant. Proc. |
pmid:10701018
|
Sens YA et al. |
Posttransplant diabetes mellitus in renal transplant patients with hepatitis C virus. |
2004 |
Transplant. Proc. |
pmid:15194304
|
Stratta RJ et al. |
Preliminary experience with FK 506 in pancreas transplant recipients. |
1995 |
Transplant. Proc. |
pmid:8539823
|